Eli Lilly vs Novartis

Eli Lilly leads Novartis by 14.6 points on the Fameproof index, and wins 2 of the three models. Measured weekly: 24 prompts × 4 runs = 96 answers per model.

Eli Lilly
Eli Lilly
Pharmaceuticals
44.3/100
Rank 49 on the companies board
Novartis
Novartis
Pharmaceuticals
29.7/100
Rank 67 on the companies board
Eli Lilly
Per-model score
Novartis
35.0
Claude
27.0
61.0
ChatGPT
20.0
37.0
Gemini
42.0
30-day movement
−1.7
Change
−2.0
Last 7 runs
Answer quality
31%
Claude mention rate
17%
63%
ChatGPT mention rate
7%
32%
Gemini mention rate
40%
15%
Claude prominence
7%
39%
ChatGPT prominence
2%
18%
Gemini prominence
14%

Questions about this comparison

Who do AI models mention more, Eli Lilly or Novartis?

Eli Lilly. It scores 44.3 on the Fameproof index against 29.7 for Novartis — a lead of 14.6 points, measured across Claude and ChatGPT and Gemini in the run of 26 October 2026.

How is the Eli Lilly vs Novartis comparison measured?

Both are asked about with the same panel of category questions — never questions naming them — repeated on every model each week. The score combines how often each is named, how early in the answer, how much of the topic is covered and how consistent the result is.

Both are ranked on the Company AI Visibility board. Prominence reflects how early in an answer the model names them; mention rate is how often it names them at all. How the score is built.

Check my company